Filter News
Area of Research
News Topics
- (-) Biomedical (2)
- (-) Isotopes (4)
- 3-D Printing/Advanced Manufacturing (9)
- Advanced Reactors (4)
- Artificial Intelligence (8)
- Big Data (2)
- Bioenergy (4)
- Biology (7)
- Biotechnology (1)
- Buildings (4)
- Chemical Sciences (9)
- Climate Change (2)
- Composites (1)
- Computer Science (14)
- Coronavirus (2)
- Critical Materials (1)
- Cybersecurity (5)
- Decarbonization (6)
- Element Discovery (1)
- Energy Storage (17)
- Environment (7)
- Exascale Computing (4)
- Fossil Energy (1)
- Frontier (6)
- Fusion (3)
- Grid (7)
- High-Performance Computing (5)
- ITER (1)
- Machine Learning (4)
- Materials (18)
- Materials Science (9)
- Microscopy (5)
- Nanotechnology (6)
- National Security (7)
- Neutron Science (10)
- Nuclear Energy (9)
- Partnerships (6)
- Physics (10)
- Polymers (3)
- Quantum Computing (2)
- Quantum Science (6)
- Security (5)
- Simulation (1)
- Space Exploration (1)
- Summit (4)
- Sustainable Energy (6)
- Transformational Challenge Reactor (2)
- Transportation (5)
Media Contacts
Several significant science and energy projects led by the ORNL will receive a total of $497 million in funding from the Inflation Reduction Act.
U.S. Secretary of Energy Jennifer Granholm visited Oak Ridge National Laboratory today to attend a groundbreaking ceremony for the U.S. Stable Isotope Production and Research Center. The facility is slated to receive $75 million in funding from the Inflation Reduction Act.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
Scientists at the Department of Energy’s Oak Ridge National Laboratory used neutrons, isotopes and simulations to “see” the atomic structure of a saturated solution and found evidence supporting one of two competing hypotheses about how ions come
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.